Syncom Formulations (India) Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Syncom Formulations (India) Limited with three other
companies in this sector in India:
Ambalal Sarabhai Enterprises Limited
sales of 1.26 billion Indian Rupees [US$17.72 million]
Jagsonpal Pharmaceuticals Limited
(1.27 billion Indian Rupees [US$17.85 million]
Kwality Pharmaceuticals Ltd
(1.37 billion Indian Rupees [US$19.40 million]
Syncom Formulations (India) Limited reported sales of 1.59 billion Indian Rupees (US$22.38 million)
March of 2018.
decrease of 14.2%
versus 2017, when the company's sales were 1.85 billion Indian Rupees.